Bibliografia
1. Composición disponible en folleto informativo.
2. Mansour et Al. Nutrients as novel therapeutic approaches for metabolic disturbances in polycystic ovary syndrome. EXCLI J. 2016 Sep 5;15:551-564.
3. Carmona-Ruiz IO, Saucedo-de-la-Llata E, Moraga Sánchez MR, Romeu-Sarrió A. Mioinositol en combinación con D-chiro-inositol: resultados preliminares en el tratamiento de primera línea de pacientes con síndrome de ovario poliquístico. Ginecol Obstet Mex. 2017 mar;85(3):141-151.
4. Inositol: Propiedades, funciones y consecuencias de su déficit. okdiario.com. https://okdiario.com/salud/inositol-funcion-56004 (Julio 2020).
5 Unfer, V., Nestler, J. E., Kamenov, Z. A., Prapas, N., & Facchinetti, F. Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials. Int J Endocrinol. 2016;2016:1849162.
6. Mendoza, N., Galan, M. I., Molina, C., Mendoza-Tesarik, R., Conde, C., Mazheika, M., Diaz-Ropero, M. P., Fonolla, J., Tesarik, J., & Olivares, M. (2019). High dose of d-chiro-inositol improves oocyte quality in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial. Gynecol Endocrinol. 2020 May;36(5):398-401.
7. Sortino MA, Salomone S, Carruba MO and Drago F.Front Pharmacol. 2017 Jun 8;8:341.
8. Caprio et Al. Myo-inositol therapy for poor-responders during IVF: a prospective controlled observational trial. J Ovarian Res.2015 Jun 12; 8:37.
9. Lisi Et Al. Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study. Reprod Biol Endocrinol. 2012 Jul 23;10:52.
10. Lerchbaum et Al. Vitamin D and fertility: a systematic review. Eur J Endocrinol. 2012 May;166(5):765-78.
11. Grundmann M, et Al. Vitamin D- roles in women’s reproductive health? Reprod Biol Endocrinol. 2011 Nov 2;9:146.
12. Drabrowski FA, et Al. The role of Vitamin D in Reproductive Health- A Trojan Horse or the Golden Fleece? Nutrients. 2015 Jun; 7(6): 4139–4153.
13. Lee B, et al. Manganese stimulates luteinizing hormone releasing hormone secretion in prepubertal female rats: hypothalamic site and mechanism of action. J Physiol. 2007 Feb 1;578(Pt 3):765-72.
14. Kamenov Z, Gateva A. Inositols in PCOS. Molecules. 2020 Nov 27;25(23):5566. doi: 10.3390/molecules25235566. PMID: 33260918; PMCID: PMC7729761.
15 Cabello, E, et alt. Effects of resveratrol on ovarian response to controlled ovarian hyperstimulation in ob/ob mice. Fertil Steril. 2015 Feb;103(2):570-9.e1. doi: 10.1016/j.fertnstert.2014.10.034. Epub 2014 Nov 20. PMID: 25467042 Más información en www.adamedfarma.es. Material elaborado en julio 2020.
2. Mansour et Al. Nutrients as novel therapeutic approaches for metabolic disturbances in polycystic ovary syndrome. EXCLI J. 2016 Sep 5;15:551-564.
3. Carmona-Ruiz IO, Saucedo-de-la-Llata E, Moraga Sánchez MR, Romeu-Sarrió A. Mioinositol en combinación con D-chiro-inositol: resultados preliminares en el tratamiento de primera línea de pacientes con síndrome de ovario poliquístico. Ginecol Obstet Mex. 2017 mar;85(3):141-151.
4. Inositol: Propiedades, funciones y consecuencias de su déficit. okdiario.com. https://okdiario.com/salud/inositol-funcion-56004 (Julio 2020).
5 Unfer, V., Nestler, J. E., Kamenov, Z. A., Prapas, N., & Facchinetti, F. Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials. Int J Endocrinol. 2016;2016:1849162.
6. Mendoza, N., Galan, M. I., Molina, C., Mendoza-Tesarik, R., Conde, C., Mazheika, M., Diaz-Ropero, M. P., Fonolla, J., Tesarik, J., & Olivares, M. (2019). High dose of d-chiro-inositol improves oocyte quality in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial. Gynecol Endocrinol. 2020 May;36(5):398-401.
7. Sortino MA, Salomone S, Carruba MO and Drago F.Front Pharmacol. 2017 Jun 8;8:341.
8. Caprio et Al. Myo-inositol therapy for poor-responders during IVF: a prospective controlled observational trial. J Ovarian Res.2015 Jun 12; 8:37.
9. Lisi Et Al. Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study. Reprod Biol Endocrinol. 2012 Jul 23;10:52.
10. Lerchbaum et Al. Vitamin D and fertility: a systematic review. Eur J Endocrinol. 2012 May;166(5):765-78.
11. Grundmann M, et Al. Vitamin D- roles in women’s reproductive health? Reprod Biol Endocrinol. 2011 Nov 2;9:146.
12. Drabrowski FA, et Al. The role of Vitamin D in Reproductive Health- A Trojan Horse or the Golden Fleece? Nutrients. 2015 Jun; 7(6): 4139–4153.
13. Lee B, et al. Manganese stimulates luteinizing hormone releasing hormone secretion in prepubertal female rats: hypothalamic site and mechanism of action. J Physiol. 2007 Feb 1;578(Pt 3):765-72.
14. Kamenov Z, Gateva A. Inositols in PCOS. Molecules. 2020 Nov 27;25(23):5566. doi: 10.3390/molecules25235566. PMID: 33260918; PMCID: PMC7729761.
15 Cabello, E, et alt. Effects of resveratrol on ovarian response to controlled ovarian hyperstimulation in ob/ob mice. Fertil Steril. 2015 Feb;103(2):570-9.e1. doi: 10.1016/j.fertnstert.2014.10.034. Epub 2014 Nov 20. PMID: 25467042 Más información en www.adamedfarma.es. Material elaborado en julio 2020.
Bibliografia
1. Composición disponible en folleto informativo.
2. Carmona-Ruiz IO, Saucedo-de-la-Llata E, Moraga Sánchez MR, Romeu-Sarrió A. Mioinositol en combinación con D-chiro-inositol: resultados preliminares en el tratamiento de primera línea de pacientes con síndrome de ovario poliquístico. Ginecol Obstet Mex. 2017 mar;85(3):141-151.
3. Inositol: Propiedades, funciones y consecuencias de su déficit. okdiario.com. https://okdiario.com/salud/inositol-funcion-56004 (Julio 2020).
4 Unfer, V., Nestler, J. E., Kamenov, Z. A., Prapas, N., & Facchinetti, F. Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials. Int J Endocrinol. 2016;2016:1849162.
5. Mendoza, N., Galan, M. I., Molina, C., Mendoza-Tesarik, R., Conde, C., Mazheika, M., Diaz-Ropero, M. P., Fonolla, J., Tesarik, J., & Olivares, M. (2019). High dose of d-chiro-inositol improves oocyte quality in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial. Gynecol Endocrinol. 2020 May;36(5):398-401.
6. Sortino MA, Salomone S, Carruba MO and Drago F.Front Pharmacol. 2017 Jun 8;8:341.
7. Caprio et Al. Myo-inositol therapy for poor-responders during IVF: a prospective controlled observational trial. J Ovarian Res.2015 Jun 12; 8:37.
8. Lisi Et Al. Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study. Reprod Biol Endocrinol. 2012 Jul 23;10:52.
9. Lerchbaum et Al. Vitamin D and fertility: a systematic review. Eur J Endocrinol. 2012 May;166(5):765-78.
10. Grundmann M, et Al. Vitamin D- roles in women’s reproductive health? Reprod Biol Endocrinol. 2011 Nov 2;9:146.
11. Drabrowski FA, et Al. The role of Vitamin D in Reproductive Health- A Trojan Horse or the Golden Fleece? Nutrients. 2015 Jun; 7(6): 4139–4153.
12. Mansour et Al. Nutrients as novel therapeutic approaches for metabolic disturbances in polycystic ovary syndrome. EXCLI J. 2016 Sep 5;15:551-564.
13. Lee B, et al. Manganese stimulates luteinizing hormone releasing hormone secretion in prepubertal female rats: hypothalamic site and mechanism of action. J Physiol. 2007 Feb 1;578(Pt 3):765-72.
14. Kamenov Z, Gateva A. Inositols in PCOS. Molecules. 2020;25(23):5566.
Más información en www.adamedfarma.es. Material elaborado en julio 2020.
2. Carmona-Ruiz IO, Saucedo-de-la-Llata E, Moraga Sánchez MR, Romeu-Sarrió A. Mioinositol en combinación con D-chiro-inositol: resultados preliminares en el tratamiento de primera línea de pacientes con síndrome de ovario poliquístico. Ginecol Obstet Mex. 2017 mar;85(3):141-151.
3. Inositol: Propiedades, funciones y consecuencias de su déficit. okdiario.com. https://okdiario.com/salud/inositol-funcion-56004 (Julio 2020).
4 Unfer, V., Nestler, J. E., Kamenov, Z. A., Prapas, N., & Facchinetti, F. Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials. Int J Endocrinol. 2016;2016:1849162.
5. Mendoza, N., Galan, M. I., Molina, C., Mendoza-Tesarik, R., Conde, C., Mazheika, M., Diaz-Ropero, M. P., Fonolla, J., Tesarik, J., & Olivares, M. (2019). High dose of d-chiro-inositol improves oocyte quality in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial. Gynecol Endocrinol. 2020 May;36(5):398-401.
6. Sortino MA, Salomone S, Carruba MO and Drago F.Front Pharmacol. 2017 Jun 8;8:341.
7. Caprio et Al. Myo-inositol therapy for poor-responders during IVF: a prospective controlled observational trial. J Ovarian Res.2015 Jun 12; 8:37.
8. Lisi Et Al. Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study. Reprod Biol Endocrinol. 2012 Jul 23;10:52.
9. Lerchbaum et Al. Vitamin D and fertility: a systematic review. Eur J Endocrinol. 2012 May;166(5):765-78.
10. Grundmann M, et Al. Vitamin D- roles in women’s reproductive health? Reprod Biol Endocrinol. 2011 Nov 2;9:146.
11. Drabrowski FA, et Al. The role of Vitamin D in Reproductive Health- A Trojan Horse or the Golden Fleece? Nutrients. 2015 Jun; 7(6): 4139–4153.
12. Mansour et Al. Nutrients as novel therapeutic approaches for metabolic disturbances in polycystic ovary syndrome. EXCLI J. 2016 Sep 5;15:551-564.
13. Lee B, et al. Manganese stimulates luteinizing hormone releasing hormone secretion in prepubertal female rats: hypothalamic site and mechanism of action. J Physiol. 2007 Feb 1;578(Pt 3):765-72.
14. Kamenov Z, Gateva A. Inositols in PCOS. Molecules. 2020;25(23):5566.
Más información en www.adamedfarma.es. Material elaborado en julio 2020.